Search results
Swiss National Bank Sells 4,500 Shares of Insteel Industries, Inc. (NASDAQ:IIIN)
ETF DAILY NEWS· 24 hours agoSwiss National Bank lessened its stake in Insteel Industries, Inc. (NASDAQ:IIIN – Free Report) by...
Swiss National Bank Reduces Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
ETF DAILY NEWS· 24 hours agoSwiss National Bank decreased its holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) by 10.3% during the fourth quarter, according ...
Swiss Steel Holding AG Announces Details of the Implementation of the Planned Reverse Stock Split
NewMediaWire via Yahoo Finance· 8 hours agoLUCERNE, Switzerland - (NewMediaWire) - May 28, 2024 - Swiss Steel Holding AG today communicates on...
Energy Recovery, Inc. (NASDAQ:ERII) Shares Sold by Swiss National Bank
ETF DAILY NEWS· 4 days agoSwiss National Bank cut its holdings in shares of Energy Recovery, Inc. (NASDAQ:ERII – Free Report)...
Swiss National Bank Trims Position in Shenandoah Telecommunications (NASDAQ:SHEN)
ETF DAILY NEWS· 4 days agoSwiss National Bank trimmed its position in shares of Shenandoah Telecommunications (NASDAQ:SHEN –...
Swiss National Bank Decreases Stock Holdings in Playa Hotels & Resorts (NASDAQ:PLYA)
ETF DAILY NEWS· 3 days agoSwiss National Bank lowered its position in Playa Hotels & Resorts (NASDAQ:PLYA – Free Report) by...
Swiss National Bank Lowers Stock Holdings in BlueLinx Holdings Inc. (NYSE:BXC)
ETF DAILY NEWS· 4 days agoSwiss National Bank reduced its holdings in BlueLinx Holdings Inc. (NYSE:BXC – Free Report) by 11.0% in the 4th quarter, according to its most recent disclosure ...
Swiss National Bank Has $1.88 Million Position in Beazer Homes USA, Inc. (NYSE:BZH)
ETF DAILY NEWS· 3 days agoSwiss National Bank lowered its stake in shares of Beazer Homes USA, Inc. (NYSE:BZH – Free Report) by 10.5% during the fourth quarter, according to the ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock Position Reduced by Swiss National Bank
ETF DAILY NEWS· 5 days agoSwiss National Bank trimmed its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 10.1% in the fourth quarter, according to its ...